SLC6A1-related epilepsy is a genetic epilepsy syndrome caused by heterozygous pathogenic variants in the [SLC6A1](/entities/slc6a1) gene, which encodes GAT-1 (GABA transporter 1), the principal transporter responsible for reuptake of GABA from the synaptic cleft. Loss of GAT-1 function leads to impaired GABA clearance, desensitization of GABA-A receptors, and network hyperexcitability. The most common phenotype is myoclonic-atonic epilepsy (MAE), also known as Doose syndrome, though the spectrum ranges from childhood absence epilepsy to severe developmental encephalopathy[@slc6a1_2015][@slc6a1_2018].
Genetics and Molecular Basis
SLC6A1 Gene
[SLC6A1](/entities/slc6a1) is located on chromosome 3p25.3 and encodes GAT-1, a sodium- and chloride-dependent GABA transporter. GAT-1 is expressed in both neurons and astrocytes and is responsible for:
Reuptake of synaptic GABA into presynaptic terminals (primary mechanism)
Astrocytic uptake of GABA for recycling or metabolism
Regulation of extracellular GABA concentrations
Prevention of GABA spillover to adjacent synapses
Pathophysiology
GAT-1 is the dominant GABA transporter in the brain. When GAT-1 function is reduced:
GABA persists longer in the synaptic cleft
Initial excessive GABA receptor activation leads to receptor desensitization
Compensatory downregulation of GABA-A receptor expression may occur
Net effect: reduced effective inhibition → network hyperexcitability
Variant Types
...
SLC6A1-Related Epilepsy
Overview
SLC6A1-related epilepsy is a genetic epilepsy syndrome caused by heterozygous pathogenic variants in the [SLC6A1](/entities/slc6a1) gene, which encodes GAT-1 (GABA transporter 1), the principal transporter responsible for reuptake of GABA from the synaptic cleft. Loss of GAT-1 function leads to impaired GABA clearance, desensitization of GABA-A receptors, and network hyperexcitability. The most common phenotype is myoclonic-atonic epilepsy (MAE), also known as Doose syndrome, though the spectrum ranges from childhood absence epilepsy to severe developmental encephalopathy[@slc6a1_2015][@slc6a1_2018].
Genetics and Molecular Basis
SLC6A1 Gene
[SLC6A1](/entities/slc6a1) is located on chromosome 3p25.3 and encodes GAT-1, a sodium- and chloride-dependent GABA transporter. GAT-1 is expressed in both neurons and astrocytes and is responsible for:
Reuptake of synaptic GABA into presynaptic terminals (primary mechanism)
Astrocytic uptake of GABA for recycling or metabolism
Regulation of extracellular GABA concentrations
Prevention of GABA spillover to adjacent synapses
Pathophysiology
GAT-1 is the dominant GABA transporter in the brain. When GAT-1 function is reduced:
GABA persists longer in the synaptic cleft
Initial excessive GABA receptor activation leads to receptor desensitization
Compensatory downregulation of GABA-A receptor expression may occur
Net effect: reduced effective inhibition → network hyperexcitability
Variant Types
| Variant Type | Frequency | Typical Impact | |-------------|-----------|----------------| | Missense | ~50% | Reduced transporter function; variable severity | | Nonsense | ~25% | Premature truncation; absent protein | | Frameshift | ~10% | Loss-of-function; typically severe | | Splice site | ~10% | Aberrant mRNA; variable | | Copy number | ~5% | Deletions/duplications |
Epidemiology
| Metric | Value | |--------|-------| | Prevalence | ~1:10,000-20,000 for MAE; SLC6A1 accounts for ~1-2% of genetic epilepsies | | Inheritance | Autosomal dominant (de novo in ~90% of cases) | | Sex ratio | Equal males and females | | Seizure onset | 1-5 years (MAE); 4-10 years (CAE) |
Clinical Presentation
Myoclonic-Atonic Epilepsy (MAE / Doose Syndrome)
The most common presentation of [SLC6A1](/entities/slc6a1) variants:
Seizure types:
Myoclonic seizures: Sudden, brief jerks of limbs or face; often multiple per day
Atonic seizures: Sudden loss of muscle tone ("drop attacks"); most disabling feature
Absence seizures: Typical 3 Hz spike-wave; may be brief